{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"SGLT2 inhibitors: Safer Teens, Stronger Kidneys, Steadier Glucose","description":"\ud83d\udea8 New trial alert! In youth with type 1 diabetes, adding #SGLT2i \ud83d\udc8a (dapagliflozin) to insulin: \u2705 Reduced glomerular hyperfiltration \u2705 Lowered HbA1c \ud83d\udcc9 \u2705 Boosted time-in-range \u23f1\ufe0f \ud83d\ude0c Safe with DKA precautions in place \ud83d\udcc4 #ATTEMPTTrial | @NatureMedicine \ud83d\udd17 https:\/\/doi.org\/10.1038\/s41591-025-03723-6 ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/36905835\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/189351340"}